Home > Income Statement > MARKSANS PHARMA

MARKSANS PHARMA
Consolidated Net Profit

    Back to Income Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Consolidated Net Profit ₹185 Cr₹236 Cr₹117,019,275 Cr₹76 Cr₹33 Cr

What is the latest Consolidated Net Profit of MARKSANS PHARMA ?

The latest Consolidated Net Profit ratio of MARKSANS PHARMA is ₹185 Cr based on Mar2023 Consolidated results.
Year Consolidated Net Profit
Mar2023₹185 Cr
Mar2022₹236 Cr
Mar2021₹117,019,275 Cr
Mar2020₹76 Cr
Mar2019₹33 Cr

How is Consolidated Net Profit of MARKSANS PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2023 ₹185 Cr
-21.77
Mar2022 ₹236 Cr
-100.00
Mar2021 ₹117,019,275 Cr
153,046,297.20
Mar2020 ₹76 Cr
132.12
Mar2019 ₹33 Cr -

Compare Consolidated Net Profit of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,514.1 Cr -1.2% 9.9% 106.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-1.2%

9.9%

106.4%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses